![Daniel Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Clark
Nessuna posizione attualmente
Profilo
Daniel Clark worked as a Manager at The Siegfried Group LLP from 2018 to 2020.
He then worked as the Chief Financial Officer at Kiromic Biopharma, Inc. from 2021 to 2022.
Clark holds an MBA from Mays Business School and an undergraduate degree from Robins E.
Claiborne School of Business.
Precedenti posizioni note di Daniel Clark
| Società | Posizione | Fine |
|---|---|---|
| KIROMIC BIOPHARMA, INC. | Direttore Finanziario/CFO | 23/12/2022 |
The Siegfried Group LLP
 The Siegfried Group LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01/02/2020 |
Formazione di Daniel Clark
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
11
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
The Siegfried Group LLP
The Siegfried Group LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Mays Business School
 Mays Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robins E. Claiborne School of Business
 Robins E. Claiborne School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiromic Biopharma, Inc.
 Kiromic Biopharma, Inc. BiotechnologyHealth Technology Develops cancer engineered immunotherapies | Health Technology |
